​

ChromaDex (CDXC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CDXC Stock Rating

ChromaDex stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

CDXC Price Target Upside V Benchmarks

TypeNameUpside
StockChromaDex-
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$7.87$7.87$7.87
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2523---5
Feb, 2523---5
Jan, 2523---5
Dec, 2423---5
Nov, 2423---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 18, 2022H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.30$-0.38$-0.21$-0.07$0.11--
Avg Forecast$-0.32$-0.43$-0.25$-0.07$0.04$0.13$0.17
High Forecast$-0.31$-0.42$-0.24$-0.07$0.06$0.23$0.20
Low Forecast$-0.32$-0.43$-0.26$-0.08$0.02$0.06$0.14
Surprise %-6.25%-11.63%-16.00%-175.00%--

Revenue Forecast

$55M $72M $89M $106M $123M $140M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$59.26M$67.45M$72.05M$83.57M$61.59M--
Avg Forecast$59.16M$68.33M$72.34M$83.20M$97.19M$118.30M$135.85M
High Forecast$59.97M$69.26M$73.72M$83.70M$98.14M$119.48M$138.63M
Low Forecast$58.34M$67.38M$70.16M$82.70M$96.25M$117.12M$130.68M
Surprise %0.16%-1.29%-0.40%0.45%-36.64%--

Net Income Forecast

$-35M $-24M $-13M $-2M $9M $20M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-18.48M$-25.56M$-14.45M$-4.94M$8.55M--
Avg Forecast$-23.81M$-32.02M$-18.75M$-5.52M$3.00M$10.26M$13.49M
High Forecast$-23.38M$-31.44M$-18.01M$-5.33M$4.50M$17.39M$15.00M
Low Forecast$-24.23M$-32.59M$-19.21M$-5.70M$1.50M$4.14M$10.50M
Surprise %-22.37%-20.19%-22.92%-10.50%185.06%--

CDXC Forecast FAQ

Is ChromaDex stock a buy?

ChromaDex stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that ChromaDex is a favorable investment for most analysts.

What is ChromaDex's price target?

ChromaDex's price target, set by 7 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $7.87.

How does ChromaDex stock forecast compare to its benchmarks?

ChromaDex's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for ChromaDex over the past three months?

  • March 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is ChromaDex’s EPS forecast?

ChromaDex's average annual EPS forecast for its fiscal year ending in December 2025 is $0.13, marking a 18.18% increase from the reported $0.11 in 2024. Estimates for the following years are.

What is ChromaDex’s revenue forecast?

ChromaDex's average annual revenue forecast for its fiscal year ending in December 2025 is $118.3M, reflecting a 92.09% increase from the reported $61.59M in 2024. The forecast for.

What is ChromaDex’s net income forecast?

ChromaDex's net income forecast for the fiscal year ending in December 2025 stands at $10.26M, representing an 19.96% increase from the reported $8.55M in 2024. Projections indicate .